ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature.

Cite this paper

@article{Luo2009ABT751AN, title={ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature.}, author={Yanping Luo and Vincent P. Hradil and David J. Frost and Saul Rosenberg and Gary Gordon and Sherry J. Morgan and Gerard D. Gagn{\'e} and Bryan F. Cox and Stephen K. Tahir and Gerard B. Fox}, journal={Anti-cancer drugs}, year={2009}, volume={20 6}, pages={483-92} }